Navigation Links
Search for salt tolerant grasses aims to improve roadside plantings
Date:7/2/2008

d, "since none of the other fescues survived."

Her next step is to take the hardiest samples, plant them in the URI turf fields, collect their seeds, and through a process of selection develop a new variety of salt tolerant grass. Then she will test it again and evaluate how well it responds to mowing.

Brown said that the "salt zone" for Rhode Island highways is from 5 to 20 feet from the edge of the pavement, which is based on the distance that cars splash winter slush. It's for use in that zone that the Department of Transportation is seeking a better grass.

The department typically plants a mix of red fescue, perennial rye grass and Kentucky bluegrass along highways, but Brown said that rye and bluegrass grow poorly in roadside soils that are typically low in fertility. She also noted that most fescues are intolerant of salt.

While the research project is driven in part because the U.S Department of Transportation mandates the use of native grasses along roadways, Brown believes that the best alternative for Rhode Island will probably be an improved variety of red fescue a plant which may have been introduced during colonial times that she hopes to develop.

"It seems to do better than our native grasses," Brown said. "We should just use it because it works."

Or, more appropriately, because it lives.


'/>"/>

Contact: Todd McLeish
tmcleish@uri.edu
401-874-7892
University of Rhode Island
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC San Diego researchers identify potential new drug candidates to combat bird flu
2. FSU researcher using computers to hone cancer-fighting strategies
3. Texas A&M researchers develop tool to study complex clusters of genes
4. Weekends slow weight loss, researchers find
5. Researchers coat titanium with polymer to improve integration of joint replacements
6. Gift of $100 million to transform energy and environment research at Princeton
7. NIAID announces grants to stimulate food allergy research
8. Researchers link early stem cell mutation to autism
9. Engineer receives $1.5M grant for nanoparticle cancer research
10. Research yields pricey chemicals from biodiesel waste
11. Montreal Heart Institute and Mount Sinai Hospital researchers contribute to Crohns disease study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...y of the September 11 attacks approaches, the Amer...st describing an array of technologies to help ass...dcast is the sixth episode in ACS,s acclaimed Glo...th new episodes posted twice monthly, Global Chall... the 21st Century, and explains how chemists and o...
(Date:9/4/2008)...hers at the HudsonAlpha Institute and Stanford Uni... other organizations, today publishes a comprehens...cer glioblastoma. These results are the first from...a collaborative effort funded by the National Canc...h Institute of the National Institutes of Health. ...
(Date:9/4/2008)...y have joined forces to develop a world-first,com... premature birth with greater accuracy., The Univ...nd Symbion Pathology are combining,expertise in m...lop a computer program to predict,women at risk o...s occur in Australia each year. Premature birth is...
(Date:9/4/2008)...eap in medicine. In the future, new tissue grown i...ew cells take the place of damaged cells in the br...ources, which opens difficult ethical and complica...g to adult human stem cells, culled from a person,...ted from various tissues in the body ― from ...
Breaking Biology News(10 mins):New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Collaboration between researchers yields more comprehensive portrait of brain cancer 2World-first to predict premature births 2Tel Aviv University researchers create new stem cell screening tool 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 1Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 30 3CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 1CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 2CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 3CEL SCI Secures Manufacturing Facility for Multikine Cancer Drug 28 4Spherix Reports Second Quarter Earnings 26 1Spherix Reports Second Quarter Earnings 26 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 1Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 2Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 3Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine 28R 29 28VNP40101M 29 in Elderly AML 24 4
...onse to cold, plants trigger a cascade of genetic ...f California, Riverside Professor of Plant Cell Bi...wn biochemical reaction regulates that genetic cas...5 online version of the Proceedings of the Nationa...ve Regulator of Plant Cold Responses, HOS1 is a RI...
...en years after the Exxon Valdez ran aground in Ala...e suggests that remnants of the worst oil spill in...n previously thought, increasing the probability t...m to wildlife. The finding appears today on the We... Environmental Science & Technology . , The s...
...in that activates estrogen receptors in breast can...ffects of anti-estrogen tamoxifen treatment, accor...ional Cancer Institute. , Pak 1 is a member of a...s, such as gene expression, cell movement, and cel... presence of this protein may lead to more invasiv...
...hich used to be referred to as Type 1 diabetes, re...ing pancreatic islet beta cells by the body,s immu...the pancreas and are made up of two types of cells... raises the level of glucose (sugar) in the blood,... appears in the May 12 issue of The Journal of Bio...
Other Biology News:Plant protection from cold decoded 2Exxon Valdez oil found in tidal feeding grounds of ducks, sea otters 2Pak1 expression increases tamoxifen resistance in breast cancer patients 2New study reveals signaling pathways required for expansion of pancreas stem cells 2New study reveals signaling pathways required for expansion of pancreas stem cells 3
(Date:9/5/2008)...-FirstCall/ -- BioSpecifics,Technologies Corp. (OT...ny,developing first in class collagenase based pro...ment to significantly improve the deal terms relat...s disease by buying down its,future royalty obliga... has modified its previously announced agreement t...
(Date:9/5/2008)... -- Campbell Alliance, the leading,management cons... biotech,industry, today announced that leaders fr...gagements at the Center for Business Intelligence,...ales Model, to be held September,8 and 9, 2008, at...ard-winning sales professional before becoming a p...
(Date:9/4/2008)...wire-FirstCall/ -- MedQuist Inc.,(Nasdaq: MEDQ ) ...ected John,F. Jastrem, Colin J. O,Brien, and Andre...2008. Prior to the election of the new directors, ...ard from seven to 10 members., According to MedQu...,pleased to have this opportunity to further enhan...
(Date:9/4/2008)...ire-FirstCall/ -- BioForm Medical,Inc. (Nasdaq: ...he fourth,quarter and full fiscal year ended June ...rter ended June 30, 2008 as compared to $15.4 mill...se of $1.3 million or 8.4%.,The net loss was $20.0...mpared to a net loss of $4.9 million for the quart...
Breaking Biology Technology:BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 2Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 3Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model 4MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 2BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 3BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 4BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 5BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 6BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 7BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 8BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008 9
...alities that separates good business executives fr...he American Heritage Dictionary defines vision as ...r intelligent foresight. Many people claim to be v...t have that ability. During the Internet dot-com f...y talked an interesting game, but when the real ch...
...v AIS is a provider of browser-based policy, clai...urability of the system allows business users to m...vention, so expensive technical resources are cons... Sciences solutions enables companies to automate...stomer service while enhancing the efficiency of b...
...as been approached by a variety of country economi...ies between regional biotech communities. These gr...The Irish ,4. The Taiwanese ,5. The Israelis ,6. T...have taken biotech more seriously and more persist...us columns, you have seen me talk about a biotech ...
...a Madison-based biotechnology company determined t...has been awarded a $250,000 Technology Development...Commerce. The company plans to use the low-interes...y technology for treating and preventing bacterial... a spectacular asset to Wisconsin, said ConjuGon p...
Other Biology Technology:Leadership is all about Vision 2Leadership is all about Vision 3Japanese Continue Relentless Biotech Stake in Midwest 2Japanese Continue Relentless Biotech Stake in Midwest 3Japanese Continue Relentless Biotech Stake in Midwest 4Japanese Continue Relentless Biotech Stake in Midwest 5Japanese Continue Relentless Biotech Stake in Midwest 6Japanese Continue Relentless Biotech Stake in Midwest 7Japanese Continue Relentless Biotech Stake in Midwest 8Japanese Continue Relentless Biotech Stake in Midwest 9
One-step, microplate or cuvet, colorimetric, linear detection range 0.7 mg/dL to 35 mg/dL. Procedure: 5 min.
assays for phosphatase, lipase, nucleoside triphosphatases (ATPase, GTPase etc). HTS and follow up studies for phosphatase inhibitors. Quantitation of phosphate content in protein, lipids, and DNA.
10% Normal Rabbit Serum from Invitrogen
EnzChek cellulase substrate *blue fluorescent, 339/452
Biology Products: